The Tri-Institutional MD-PhD Program (Tri-I) is a joint undertaking between Weill Cornell Medicine, The Rockefeller University, and Memorial Sloan Kettering Cancer Center. Trainees complete their MD degree at Weill Cornell Medical College, and PhD training at one of the three participating graduate schools: Weill Cornell Graduate School of Medical Sciences; the David Rockefeller Graduate Program in Bioscience; or the Louis V. Gerstner Jr. Graduate School of Biomedical Sciences. Tri-I guides students through a rigorous course of study that offers flexibility and unfettered access to experienced mentors in leading laboratories. An integrated curriculum reinforces the students’ identities as clinician-scientists; equally well-prepared to work in the laboratory and at the bedside, Tri-I graduates bridge the gap between clinical medicine and laboratory research. 

Learn more about the Tri-Institutional MD-PhD Program by watching the short video below.

Current Tri-Institutional MD-PhD student, Margaret Herre, has received an F30 award from the National Institutes of Health - National Institute on Deafness and Other Communication Disorders (NIH/NIDCD) for her project "Hormone regulation of olfactory sensory neuron function in the Zika vector Aedes aegypti".
Fifth year Tri-Institutional MD-PhD student Jenny Xue (pictured below) was awarded an F30 fellowship from the National Cancer Institute for her project titled “Dissecting the evolution of targeted therapy resistance in BRAF V600E-mutant cancer”.